Freli V. et al. Presented at GFHGHP 2012. Presented as oral communication at the 33rd edition of the Congress from the Groupe Francophone d’Hépato-Gastroentérologie et Nutrition Pédiatriques in Nantes, France, March 2012. Abstract: New insights into the mechanism of action of gelatine tannate for acute diarrhoea. Part 1: filmforming effect. [...]
Kim YS, Ho SB. Curr Gastroenterol Rep. 2010 Oct;12(5):319-30 The mucus layer coating the gastrointestinal tract is the front line of innate host defense, largely because of the secretory products of intestinal goblet cells. Goblet cells synthesize secretory mucin glycoproteins (MUC2) and bioactive molecules such as epithelial membrane-bound mucins (MUC1, [...]
Hai Li, Julien P. Limenitakis, Tobias Fuhrer, Markus B. Geuking, Melissa A. Lawson, Madeleine Wyss, Sandrine Brugiroux, Irene Keller, Jamie A. Macpherson, Sandra Rupp, Bettina Stolp, Jens V. Stein, Bärbel Stecher, Uwe Sauer, Kathy D. McCoy & Andrew J. Mac Nature Communications 6, Article number: 8292 (2015) The overall [...]
Jess Torres-Herrera, and Gabriel Torres-Ruiz. Current Drug Therapy, 2017, 12, 1-6 Background: Gelatin tannate is bowel selective, safe and effective, and acts locally to form a biofilm. As an adjuvant to oral rehydration solution (ORS), gelatin tannate acts as a mucoprotectant in the management of acute diarrhea in children. Objective: [...]
Takashi Kojima, Mitsuru Go, Ken-ichi Takano, Makoto Kurose, Tsuyoshi Ohkuni, Jun-ichi Koizumi, Ryuta Kamekura, Noriko Ogasawara, Tomoyuki Masaki, Jun Fuchimoto, Kazufumi Obata, Satoshi Hirakawa, Kazuaki Nomura, Takashi Keira, Ryou Miyata, Nobuhiro Fujii, Hiroyuki Tsutsumi, Tetsuo Himi and Norimasa Sawada BioMed Research International, Volume 2013 (2013), Article ID 947072, 11 [...]
L. Lopetuso, C. Graziani, A. Guarino, A. Lamborghini, S. Masi, V. Stanghellini Eur Rev Med Pharmacol Sci . 2017; 21 (4): 873-883 Objective: Intestinal permeability impairment is implicated in many gastrointestinal (GI) diseases. Chronic diarrhea, defined as the presence of diarrhea for more than 3 weeks in adults and 2 [...]
Catalin Pleasea Condratovici, Xavier Llop, Núria Piqué, Vladimir Bacarea. 23rd UEG WEEK BARCELONA. October 24-28 2015 [...]
Catalin Pleasea Condratovici, Vladimir C. Bacârea, Núria Piqué. Gastroenterology Research and Practice. April 2016 Background: Xyloglucan, a film-forming agent, improves intestinal mucosa resistance to pathologic damage. The efficacy, safety, and time of onset of the antidiarrheal effect of xyloglucan were assessed in children with acute gastroenteritis receiving oral rehydration solution [...]
Soner Sertan Kara, Burcu Volka2, Ibrahim Erten. G-eP-020. ESPGHAN 50th Annual Meeting – Abstracts. May 2017. Pag 114 Objectives and study: Acute gastroenteritis (AGE) is a common cause of morbidity and mortality worldwide. The management of children and infants with viral AGE mainly depends on oral or intravenous hydration, breastfeeding, [...]
Çağan E, Ceylan S, Mengi Ş, Çağan HH. Med Sci Monit. 2017 Apr 27;23:2029-2034. Background: Acute diarrhea is the second most common cause of morbidity and mortality worldwide, especially in children aged ≤3 years. Some drugs (e.g., the mucoprotector gelatin tannate) plus a reduced osmolality oral rehydration solution (ORS) may [...]
